Todos Med Ltd (TOMDF)

[misiu143]

I am listening to this conference now ..
According to Dr Patterson we may see replicating virus in long covid but only in the first few months , we don't see it after 4 months anymore.

We may see parts of S1 protein in monocytes even at 15 months in some , and in tissue at 12 months , they may not replicate , but our immune system is reacting to this RNA parts......

Some patients just have disregulated immune system , so immune modulators are important in long covid .

He is using maraviroc , CCR5 inhibitor as an immune modulator , and he like it , personally I be worry since maraviroc has black box warning for liver injury . and during HIV study 2 young patients developed liver failure within 2-3 weeks of using , and one needed liver transplant..
Leronlimab will be perfect here , but it is not yet approved ..

All this tell us that Paxlovid will have a very limited benefit in long covid , mostly at the beginning when we still may see replicating virus..

Tollovir/Tollovid should be very good at any time of long covid , since it is an antiviral and immune modulator.
This is why we hearing most of this patients taking now Tollovid doing very well..

In some long covid we see activation of other , previously present viruses , like Eb , herpes etc , so Dr Patterson add at times Valtrex ..
Also sometimes activation of Lyme Disease , so he is treating this infection accordingly ...

It is a good conference so far..

GLTA longs.